• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Jan / 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Dec    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing

Tedros Adhanom Ghebreyesus, Director-General

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera

Adham Jurdi

OncoCalendar

1 event found.

Dusit Thani Hotel, Abu Dhabi

« All Events
Address
925 Sultan Bin Zayed The First Street
Abu Dhabi, 00000 United Arab Emirates
Get Directions
Phone +971 2 698 8888
Website https://www.dusit.com/dusitthani-abudhabi/

Events at this venue

Today
  • April 2025

  • Sat 26
    EPHOC 2025
    Apr 26, 2025 • 8:00 AM - Apr 27, 2025 • 5:00 PM

    The 7th Emirates Pediatric Hematology and Oncology Conference

    Dusit Thani Hotel, Abu Dhabi 925 Sultan Bin Zayed The First Street, Abu Dhabi, United Arab Emirates

    The 7th Emirates Pediatric Hematology and Oncology Conference will be held from April 26-27, 2025 at Abu Dhabi, UAE. The 7th Emirates Pediatric Hematology and Oncology Conference (EPHOC) will focus on the diagnosis and management of common hematological and oncological conditions in children. The conference is designed for healthcare professionals, including pediatricians, subspecialists, residents, fellows, […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer prostate cancer AACR clinical trials FDA UICC Dana-Farber Cancer Institute European Cancer Organisation American Cancer Society SIOP NCI chemotherapy Myeloma National Cancer Institute Robert Orlowski American Society of Clinical Oncology Vivek Subbiah healthcare Myeloma Paper of the Day Paolo Tarantino AI IASLC Pancreatic Cancer ASCO25 radiation oncology WHO multiple myeloma cervical cancer Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}